Phospho-DOK2 (Y345) Antibody

What is Phospho-DOK2 (Y345) Antibody and what epitope does it recognize?

Phospho-DOK2 (Y345) Antibody is a rabbit polyclonal antibody specifically designed to detect endogenous levels of DOK2 protein only when phosphorylated at tyrosine 345. The antibody is raised against a synthesized peptide derived from human DOK2 (UniProt ID: O60496) corresponding to the region surrounding the phosphorylated Tyr345 residue . This antibody is highly specific and does not recognize non-phosphorylated DOK2 or other phosphorylation sites, making it valuable for studying phosphorylation-dependent signaling events involving DOK2 .

What are the validated applications and recommended dilutions for this antibody?

Phospho-DOK2 (Y345) Antibody has been validated for multiple research applications with specific recommended dilutions:

• Western Blot (WB): Primary application with recommended dilutions typically 1:1000

• Enzyme-Linked Immunosorbent Assay (ELISA): Recommended dilution 1:20000

• Immunohistochemistry (IHC): Recommended dilution range 1:100-1:300

These applications enable researchers to study phosphorylated DOK2 in various experimental contexts, from protein lysates to tissue sections .

What are the optimal storage conditions for maintaining antibody activity?

To maintain optimal antibody activity, Phospho-DOK2 (Y345) Antibody should be:

• Stored at -20°C to -80°C for long-term preservation

• Aliquoted upon receipt to avoid repeated freeze-thaw cycles that may degrade antibody quality

• Kept in a storage buffer containing PBS with 50% glycerol, 0.5% BSA, and 0.02% sodium azide (pH 7.4)

When properly stored, the antibody maintains its activity and specificity for the duration of its shelf life .

How should samples be prepared to preserve phosphorylation status for Phospho-DOK2 (Y345) detection?

Preserving phosphorylation status is critical when working with phospho-specific antibodies. For optimal Phospho-DOK2 (Y345) detection:

• Include phosphatase inhibitors in lysis buffers (e.g., sodium orthovanadate, sodium fluoride)

• Maintain cold temperatures during sample processing to minimize phosphatase activity

• Process samples rapidly to prevent degradation

• For tissue samples, snap-freeze in liquid nitrogen immediately after collection

• When applicable, consider treatments that induce DOK2 phosphorylation (e.g., TNF-α for HeLa cells)

These precautions help maintain the native phosphorylation state of DOK2, ensuring accurate experimental results .

What controls should be included when using Phospho-DOK2 (Y345) Antibody?

Rigorous experimental design requires appropriate controls when using phospho-specific antibodies:

What are the recommended secondary antibodies and detection methods?

For optimal detection of Phospho-DOK2 (Y345) Antibody:

• Use anti-rabbit IgG secondary antibodies, as this is a rabbit polyclonal antibody

• Compatible conjugates include:

  • Horseradish peroxidase (HRP) for chemiluminescent detection

  • Alkaline phosphatase (AP) for colorimetric detection

  • Fluorophores (FITC, Cy3, Alexa Fluor) for fluorescent detection

  • Biotin for amplified detection systems

The choice of secondary antibody and detection method should align with your instrumentation and sensitivity requirements .

How does DOK2 Y345 phosphorylation relate to chronic myelogenous leukemia (CML) research?

DOK2 phosphorylation at Y345 has significant implications for CML research:

• DOK2 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from CML patients in the chronic phase

• It may function as a critical substrate for p210(bcr/abl), a chimeric protein associated with CML pathogenesis

• Phosphorylated DOK2 binds p120 (RasGAP) from CML cells, potentially affecting downstream signaling pathways

• Monitoring DOK2 phosphorylation status could provide insights into disease progression or treatment response

Using Phospho-DOK2 (Y345) Antibody allows researchers to investigate these mechanisms in detail, potentially contributing to therapeutic target identification .

How can mass spectrometry complement antibody-based detection of phosphorylated DOK2?

Mass spectrometry offers complementary approaches to phospho-specific antibodies:

• Provides site-specific confirmation of phosphorylation at Y345 and other sites

• Enables unbiased discovery of novel phosphorylation sites on DOK2

• Allows quantification of phosphorylation stoichiometry

• Can identify phosphorylation-dependent binding partners through phosphoproteomic approaches

• Facilitates analysis of multiple post-translational modifications simultaneously

Combining antibody-based detection with mass spectrometry strengthens phosphorylation research by overcoming the limitations of each individual technique .

What is known about the temporal dynamics of DOK2 Y345 phosphorylation after stimulation?

Understanding the temporal dynamics of phosphorylation events is crucial for mechanistic studies:

• DOK2 Y345 phosphorylation can be rapidly induced by treatments such as TNF-α in HeLa cells

• The timing of phosphorylation may vary depending on:

  • Cell type and differentiation state

  • Stimulus type and concentration

  • Presence of other signaling pathway components

• Time-course experiments using the Phospho-DOK2 (Y345) Antibody can reveal:

  • Onset of phosphorylation after stimulation

  • Peak phosphorylation levels

  • Duration and decay kinetics

Time-resolved analysis provides insights into the functional significance of DOK2 phosphorylation in signal transduction cascades .

What are common challenges when using Phospho-DOK2 (Y345) Antibody and how can they be resolved?

Researchers may encounter several challenges when working with phospho-specific antibodies:

Addressing these challenges systematically improves experimental outcomes and data reliability .

How can researchers verify the specificity of bands detected with Phospho-DOK2 (Y345) Antibody?

Verifying antibody specificity is essential for accurate data interpretation:

• Perform peptide competition assays using the phospho-peptide immunogen to block specific binding

• Compare samples with and without phosphatase treatment to demonstrate phosphorylation dependence

• Use DOK2 knockout or knockdown models as negative controls

• Compare band patterns with antibodies targeting total DOK2 or other phosphorylation sites

• Consider molecular weight confirmation (DOK2 appears at approximately 56 kDa)

These verification steps enhance confidence in experimental findings and strengthen publication-quality data .

How should researchers approach contradictory results when studying DOK2 phosphorylation across different experimental systems?

When faced with contradictory results:

• Critically compare experimental conditions, as phosphorylation is highly context-dependent

• Verify antibody specificity using the methods described above

• Consider cell type-specific differences in:

  • DOK2 expression levels

  • Phosphatase activity

  • Upstream kinase expression and activation

  • Availability of scaffolding proteins

• Evaluate the influence of culture conditions or animal models on signaling pathway activity

• Use complementary techniques (mass spectrometry, proximity ligation assays) to validate findings

A systematic approach to resolving contradictions can reveal important biological insights about context-specific signaling mechanisms .

How might Phospho-DOK2 (Y345) Antibody contribute to biomarker development in hematological malignancies?

Phospho-DOK2 (Y345) Antibody could advance biomarker research through:

• Immunohistochemical analysis of patient samples to correlate phosphorylation status with:

  • Disease progression

  • Treatment response

  • Patient outcomes

  • Molecular subtypes

• Development of phosphorylation-based diagnostic assays

• Identification of patients likely to respond to targeted therapies

• Monitoring treatment efficacy in real-time

These applications could potentially improve patient stratification and personalized treatment approaches .

What methodological advances might enhance phospho-specific antibody research in the future?

Emerging methodologies that could enhance phospho-specific antibody research include:

• Single-cell phospho-protein analysis to reveal cellular heterogeneity

• Multiplexed immunofluorescence to examine multiple phosphorylation events simultaneously

• Phospho-proteomics integration with antibody-based validation

• Advanced imaging techniques for spatiotemporal phosphorylation dynamics

• Development of phosphorylation-state specific nanobodies with improved tissue penetration and specificity

These technological advances may address current limitations and expand the utility of phospho-specific antibodies in research .

How can researchers integrate Phospho-DOK2 (Y345) Antibody data with broader signaling network analysis?

Integration of Phospho-DOK2 (Y345) data with broader signaling networks requires:

• Simultaneous analysis of multiple phosphorylation sites on DOK2 and related proteins

• Correlation of DOK2 phosphorylation with activation states of upstream kinases and downstream effectors

• Computational modeling of signaling networks incorporating phosphorylation kinetics

• Systems biology approaches to place DOK2 phosphorylation in context of cellular phenotypes

• Integration with transcriptomic and proteomic datasets to identify phosphorylation-dependent gene expression changes

This integrative approach provides a more comprehensive understanding of DOK2's role in complex signaling networks .